{
 "drug": "Albuterol Sulfate Solution",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "10/25/2022",
 "dayN": 1400,
 "cat": "Pulmonary/Allergy",
 "companies": [
  "Nephron Pharmaceuticals Corporation",
  "Ritedose Pharmaceuticals, LLC",
  "Rising Pharma Holdings, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "update_type": "Revised",
   "initial_posting_date": "10/25/2022",
   "package_ndc": "0487-9901-30",
   "generic_name": "Albuterol Sulfate Solution",
   "contact_info": "800-443-4313",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA075664"
    ],
    "brand_name": [
     "ALBUTEROL SULFATE"
    ],
    "generic_name": [
     "ALBUTEROL SULFATE"
    ],
    "manufacturer_name": [
     "Nephron Pharmaceuticals Corporation"
    ],
    "product_ndc": [
     "0487-9901"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RESPIRATORY (INHALATION)"
    ],
    "substance_name": [
     "ALBUTEROL SULFATE"
    ],
    "rxcui": [
     "245314"
    ],
    "spl_id": [
     "30dbae21-c906-0624-e063-6394a90a299c"
    ],
    "spl_set_id": [
     "ecc00500-58b8-491f-80df-dc6c89a08cae"
    ],
    "package_ndc": [
     "0487-9901-30",
     "0487-9901-02"
    ],
    "unii": [
     "021SEF3731"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Pulmonary/Allergy",
    "Pediatric"
   ],
   "dosage_form": "Solution",
   "presentation": "Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 0487-9901-30)",
   "company_name": "Nephron Pharmaceuticals Corporation",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/25/2022",
   "package_ndc": "76204-027-01",
   "generic_name": "Albuterol Sulfate Solution",
   "contact_info": "803-806-3300",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA218386"
    ],
    "brand_name": [
     "ALBUTEROL SULFATE INHALATION SOLUTION, 0.5%"
    ],
    "generic_name": [
     "ALBUTEROL SULFATE"
    ],
    "manufacturer_name": [
     "Ritedose Pharmaceuticals, LLC"
    ],
    "product_ndc": [
     "76204-027"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RESPIRATORY (INHALATION)"
    ],
    "substance_name": [
     "ALBUTEROL SULFATE"
    ],
    "rxcui": [
     "245314"
    ],
    "spl_id": [
     "4e7f86ab-55bc-c123-e063-6394a90abd8d"
    ],
    "spl_set_id": [
     "fdb4ac5a-bf0d-4896-89f7-1828c081b79e"
    ],
    "package_ndc": [
     "76204-027-11",
     "76204-027-01"
    ],
    "unii": [
     "021SEF3731"
    ]
   },
   "update_date": "08/04/2026",
   "therapeutic_category": [
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Solution",
   "presentation": "Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 76204-027-01)",
   "company_name": "Ritedose Pharmaceuticals, LLC",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "10/25/2022",
   "package_ndc": "64980-642-03",
   "generic_name": "Albuterol Sulfate Solution",
   "contact_info": "201-961-9000",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "ANDA075664"
    ],
    "brand_name": [
     "ALBUTEROL SULFATE"
    ],
    "generic_name": [
     "ALBUTEROL SULFATE"
    ],
    "manufacturer_name": [
     "Rising Pharma Holdings, Inc."
    ],
    "product_ndc": [
     "64980-642"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "RESPIRATORY (INHALATION)"
    ],
    "substance_name": [
     "ALBUTEROL SULFATE"
    ],
    "rxcui": [
     "245314"
    ],
    "spl_id": [
     "56c00cc1-5ed0-8ff5-e063-6394a90a132b"
    ],
    "spl_set_id": [
     "3236f82c-14e9-dfd4-e063-6294a90ac43d"
    ],
    "package_ndc": [
     "64980-642-03"
    ],
    "unii": [
     "021SEF3731"
    ]
   },
   "update_date": "06/03/2026",
   "therapeutic_category": [
    "Pediatric",
    "Pulmonary/Allergy"
   ],
   "dosage_form": "Solution",
   "presentation": "Albuterol Sulfate, Solution, 2.5 mg/.5 mL (NDC 64980-642-03)",
   "company_name": "Rising Pharma Holdings, Inc.",
   "status": "Current"
  }
 ]
}